Exclusive special offer and discount title banner vector image

GLOBAL ARTIFICIAL BLOOD VESSELS MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Global Artificial Blood Vessels Market by Type (Expanded Polytetrafluoroethylene, Polyethylene Terephthalate, Polyurethane, Other Types) Market by Blood Vessel Diameter (Large, Medium, Small) Market by Patient Demographics (Pediatric, Adult) Market by Application (Peripheral Artery, Hemodialysis, Aortic Disease) Market by End-user (Hospital, Specialty Clinic, Ambulatory Surgical Center, Other End-users) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The global artificial blood vessels market size was $3588.59 million in 2023 and is expected to reach $6140.48 million by 2032, growing at a CAGR of 6.04% during the forecast period 2024–2032. 

The global artificial blood vessels market is driven by factors such as the high prevalence of cardiovascular diseases and significant advancements in blood vessel replacement materials. The demand for synthetic artificial blood vessels is particularly pronounced in surgeries addressing conditions like coronary artery disease and peripheral artery disease. Technological innovations, such as 3D printing for creating artificial blood vessels, have revolutionized the industry by offering customized solutions and enhancing surgical outcomes. 

The development of advanced materials has improved the durability and biocompatibility of artificial blood vessels, effectively meeting the diverse needs of patients. Furthermore, the rising aging population, which is more susceptible to cardiovascular ailments, is a key factor driving the demand for artificial blood vessels and necessitating frequent surgical interventions. These trends indicate a steady growth trajectory for the global artificial blood vessels market, with opportunities for further innovation and market penetration in minimally invasive surgical techniques and artificial blood for transfusion.

Global Artificial Blood Vessels Market Size

Read our latest blog on the Artificial Blood Vessels Market

GROWTH ENABLERS

Key growth enablers of the global artificial blood vessels market:

  • Rising prevalence of cardiovascular diseases and vascular disorders
    • The increasing prevalence of cardiovascular diseases (CVDs) globally is driving the demand for artificial blood vessels. CVDs, the leading cause of death worldwide according to the WHO, claim approximately 18.6 million lives annually. In parallel, in the United States, heart disease, the primary contributor to CVD-related deaths, results in over 697,000 fatalities each year and affects around 121.5 million adults. Stroke, another significant vascular disorder, contributes substantially to disability and mortality, with nearly 800,000 cases reported annually.
    • The economic burden of CVDs surpasses $1 trillion annually, substantially affecting global productivity. Consequently, there is an urgent need for innovative treatments. Artificial blood vessels, crucial in surgical procedures such as coronary artery bypass grafting and peripheral artery bypasses, are vital in restoring blood flow and improving patient outcomes, effectively addressing the challenges posed by CVDs and other vascular disorders.
  • Advancements in tissue engineering and regenerative medicine
  • Growing geriatric population and changing lifestyles

GROWTH RESTRAINTS

Key growth restraining factors of the global artificial blood vessels market:

  • High costs associated with the development and commercialization of artificial blood vessels
  • Stringent regulatory approvals and clinical trial requirements
    • Stringent regulatory approvals and extensive clinical trial requirements present considerable challenges for the global artificial blood vessels market. These requirements, mandated by regulatory bodies like the FDA in the United States and similar authorities worldwide, are crucial for ensuring the safety and efficacy of medical devices. However, they result in prolonged approval timelines and increased costs for manufacturers. 
    • Compliance with high-risk classification standards adds additional complexity, requiring extensive preclinical and clinical data reviews. The rigorous criteria for clinical trials, which span multiple phases and demand substantial financial investment and specialized expertise, create barriers to market entry and product commercialization. 
    • Moreover, the introduction of stricter regulations, such as the European Union Medical Device Regulation, exacerbates these challenges, increasing the complexity of the approval process. 
  • Concerns regarding biocompatibility and long-term durability

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Artificial Blood Vessels Market | Top Market Trends 

  • A notable trend in the global artificial blood vessels market is the increasing utilization of 3D bioprinting techniques. Traditional artificial blood vessels often rely on synthetic materials or cadaveric vessels, which may have limited durability and pose risks of complications. However, 3D bioprinting offers an innovative approach by enabling the creation of patient-specific, biocompatible vascular grafts. For instance, researchers at the University of Minnesota have achieved a significant milestone by bioprinting a life-sized model of a patient’s cardiovascular system. Therefore, this breakthrough paves the way for producing customized vascular grafts that closely mimic the properties and structures of natural blood vessels. Advancements in 3D bioprinting hold immense potential for improving the efficacy and safety of artificial blood vessel implants, thereby transforming treatment paradigms for cardiovascular diseases.
  • Another key trend in the global artificial blood vessels market is the increasing incorporation of nanotechnology and biomimetic materials. Nanotechnology, which involves manipulating materials at the nanoscale, offers unique opportunities to enhance the properties and performance of artificial blood substitutes. Additionally, biomimetic materials, designed to mimic the structure and function of natural biological systems, provide a more compatible and effective alternative to traditional synthetic materials. This trend underscores a growing emphasis on leveraging advanced scientific principles to develop artificial blood vessels with improved biocompatibility, durability, and performance, thereby enhancing patient outcomes and expanding the scope of treatment options for cardiovascular diseases.

MARKET SEGMENTATION

Global Artificial Blood Vessels Market Share

Need a custom report or have specific data requirements? Let us know!

Market Segmentation – Type, Blood Vessel Diameter, Patient Demographics, Application, and End-User –

Market by Type: 

  • Expanded Polytetrafluoroethylene (ePTFE)
    • The expanded polytetrafluoroethylene (ePTFE) segment is estimated to be the fastest-growing type category during the forecast period. 
    • Expanded Polytetrafluoroethylene (ePTFE) is a synthetic fluoropolymer material extensively employed in the production of artificial blood vessels. It features a unique microporous structure characterized by interconnected nodes and fibrils, facilitating tissue ingrowth and enhancing biocompatibility. The microporous nature of ePTFE enables it to mimic the properties of natural blood vessels, promoting adequate blood flow and minimizing the risk of thrombosis or occlusion.
    • ePTFE exhibits exceptional chemical resistance, making it inert to bodily fluids and substances, thereby enhancing its durability for long-term implantation. Additionally, this material demonstrates high tensile strength and flexibility, allowing it to withstand the pressure and pulsatile flow within the cardiovascular system.
    • Manufacturers utilize techniques such as stretching, sintering, and surface modifications to enhance the surface characteristics of ePTFE grafts. These processes aim to optimize cellular adhesion, endothelialization, and integration within the body, ultimately improving the performance and longevity of the implanted grafts.
    • While ePTFE is widely used in vascular surgery, particularly for bypass procedures and arteriovenous access for hemodialysis, ongoing research is focused on potential modifications to further enhance its efficacy. Strategies include incorporating bioactive molecules, altering surface topography, or combining ePTFE with other materials to improve properties such as antithrombogenicity and cellular compatibility.
  • Polyethylene Terephthalate (PET)
  • Polyurethane
  • Other Types

Market by Blood Vessel Diameter:

  • Large
    • Large artificial blood vessel grafts typically have a diameter ranging from 6 mm to 30 mm or larger, designed to replace or bypass major blood vessels like the aorta, iliac arteries, or femoral arteries.
    • Further, these grafts are engineered to endure the high pressures and flow rates of the cardiovascular system’s major blood vessels. Large artificial blood vessel grafts are commonly used in procedures such as aortic aneurysm repair, where a section of the aorta, the body’s main artery, is replaced with a synthetic graft. The selection of the appropriate graft material and design for large blood vessel applications depends on various factors, including the specific location and diameter of the vessel being replaced, the anticipated blood flow rates and pressures, and the patient’s characteristics.
    • Looking ahead, manufacturers use various techniques to optimize the performance of large artificial blood vessel grafts. These techniques may include incorporating reinforcement layers or rings to maintain patency and prevent kinking or collapsing, as well as surface modifications to enhance biocompatibility and reduce the risk of thrombosis or infections. Large artificial blood vessel grafts are typically employed in open surgical procedures, where the graft is sutured or anastomosed to the existing blood vessels.
  • Medium
  • Small 

Market by Patient Demographics:

  • Pediatric
  • Adult

Market by Application:

  • Peripheral Artery 
  • Hemodialysis
  • Aortic Disease

Market by End-User:

  • Hospital
  • Specialty Clinic
  • Ambulatory Surgical Center
  • Other End-Users

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions: 
  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Switzerland, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • The Asia-Pacific is anticipated to be the leading region over the forecasted years.
    • The Asia-Pacific has witnessed substantial growth in the global artificial blood vessels market, driven by several key factors. Notably, the increasing prevalence of cardiovascular diseases throughout the region has heightened the demand for vascular grafts and related medical procedures.
    • The aging populations in countries such as Japan and China have further fueled market growth, as elderly individuals are more prone to conditions that necessitate vascular interventions.
    • Moreover, the enhancement of healthcare infrastructure and rising healthcare expenditures in developing nations across the Asia-Pacific have improved access to advanced medical treatments, including vascular surgeries.
    • In focus, key players in the market, including Terumo Corporation and W L Gore & Associates Inc, have leveraged these favorable conditions to further propel the market’s growth.
  • Rest of World: Latin America, the Middle East & Africa
Our market research reports offer an in-depth analysis of individual country-level market size and growth statistics. We cover the segmentation analysis, key growth factors, and macro-economic trends within the artificial blood vessels market, providing detailed insights into – 

MAJOR PLAYERS

Major players in the global artificial blood vessels market: 

  • B Braun Melsungen AG
  • Becton Dickinson and Company
  • LeMaitre Vascular INC
  • Medtronic plc
  • Terumo Medical Corporation

Key strategies adopted by some of these companies:

  • Getinge acquired Applikon Biotechnology in January 2020. Applikon specializes in the development and supply of advanced bioreactor systems for the research and production of vaccines and antibodies in the biopharmaceutical industry, as well as enzymes and bio-plastics for industrial biotechnology.
  • Becton Dickinson and Company acquired Venclose Inc on December 2, 2021, thereby expanding its portfolio to include solutions for chronic venous insufficiency (CVI) treatment. Venclose’s innovative Radio Frequency (RF) ablation technology platform addresses a significant therapeutic need, affecting up to 40% of women and 17% of men in the United States.
  • W L Gore & Associates announced a collaboration with Arzeda, a Protein Design Company™, on June 27, 2022. This partnership focuses on leveraging Arzeda’s technology platform to efficiently create and enhance proteins. With increasing demand for innovative and sustainably produced materials, both companies aim to meet consumer needs for performance and sustainability. By optimizing bio-based and biodegradable proteins, the collaboration seeks to improve material performance while minimizing waste and resource intensity in manufacturing processes.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedType, Blood Vessel Diameter, Patient Demographics, Application, and End-User
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

B Braun Melsungen AG, Becton Dickinson and Company, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, W L Gore & Associates, Artivion Inc, Getinge AB, MicroPort Scientific Corporation, Jiangsu Bioda Life Science Co Ltd, Roumai Medical, MedicalExpo, Vascular Graft Solution

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON THE GLOBAL ARTIFICIAL BLOOD VESSELS MARKET
    5. MAJOR MARKET FINDINGS
      1. AORTIC DISEASES INCREASE IS SEEN AS A CATALYST FOR MARKET GROWTH
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES AND VASCULAR DISORDERS
      2. ADVANCEMENTS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
      3. GROWING GERIATRIC POPULATION AND CHANGING LIFESTYLES
    2. KEY RESTRAINTS
      1. HIGH COSTS ASSOCIATED WITH THE DEVELOPMENT AND COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS
      2. STRINGENT REGULATORY APPROVALS AND CLINICAL TRIAL REQUIREMENTS
      3. CONCERNS REGARDING BIOCOMPATIBILITY AND LONG-TERM DURABILITY
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. DEVELOPMENT OF 3D BIOPRINTING TECHNIQUES FOR CUSTOMIZED VASCULAR GRAFTS
      2. INCORPORATION OF NANOTECHNOLOGY AND BIOMIMETIC MATERIALS FOR IMPROVED FUNCTIONALITY
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR NORTH AMERICA
      2. GROWTH PROSPECT MAPPING FOR EUROPE
      3. GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
      4. GROWTH PROSPECT MAPPING FOR REST OF WORLD
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTORS
      4. END-USER
    7. KEY BUYING CRITERIA
      1. BIOCOMPATIBILITY
      2. DURABILITY AND LONGEVITY
      3. CUSTOMIZATION AND VERSATILITY
      4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
  5. MARKET BY TYPE
    1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)
    2. POLYETHYLENE TEREPHTHALATE (PET)
    3. POLYURETHANE
    4. OTHER TYPES
  6. MARKET BY BLOOD VESSEL DIAMETER
    1. LARGE
    2. MEDIUM
    3. SMALL
  7. MARKET BY PATIENT DEMOGRAPHICS
    1. PEDIATRIC
    2. ADULT
  8. MARKET BY APPLICATION
    1. PERIPHERAL ARTERY
    2. HEMODIALYSIS
    3. AORTIC DISEASE
  9. MARKET BY END-USER
    1. HOSPITAL
    2. SPECIALTY CLINIC
    3. AMBULATORY SURGICAL CENTER
    4. OTHER END-USERS
  10. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET DRIVERS
      3. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET CHALLENGES
      4. NORTH AMERICA ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE ARTIFICIAL BLOOD VESSELS MARKET DRIVERS
      3. EUROPE ARTIFICIAL BLOOD VESSELS MARKET CHALLENGES
      4. EUROPE ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE ARTIFICIAL BLOOD VESSELS MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        6. SWITZERLAND
          1. SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET DRIVERS
      3. ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET CHALLENGES
      4. ASIA-PACIFIC ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET DRIVERS
      3. REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET CHALLENGES
      4. REST OF WORLD ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD VESSELS MARKET SIZE & OPPORTUNITIES
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. B BRAUN MELSUNGEN AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      2. BECTON DICKINSON AND COMPANY
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      3. LEMAITRE VASCULAR INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      4. MEDTRONIC PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      5. TERUMO MEDICAL CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      6. W L GORE AND ASSOCIATES
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      7. ARTIVION INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      8. GETINGE AB
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      9. MICROPORT SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      10. JIANGSU BIODA LIFE SCIENCE CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      11. ROUMAI MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      12. MEDICALEXPO
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES
      13. VASCULAR GRAFT SOLUTION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – GLOBAL ARTIFICIAL BLOOD VESSELS 

TABLE 2: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GLOBAL EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE) MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GLOBAL POLYETHYLENE TEREPHTHALATE (PET) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL POLYETHYLENE TEREPHTHALATE (PET) MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GLOBAL POLYURETHANE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL POLYURETHANE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GLOBAL LARGE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL LARGE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GLOBAL MEDIUM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL MEDIUM MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: GLOBAL SMALL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL SMALL MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 20: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 22: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 24: GLOBAL ADULT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL ADULT MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 26: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 28: GLOBAL PERIPHERAL ARTERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL PERIPHERAL ARTERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 30: GLOBAL HEMODIALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL HEMODIALYSIS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 32: GLOBAL AORTIC DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL AORTIC DISEASE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 34: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 36: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 38: GLOBAL SPECIALTY CLINIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL SPECIALTY CLINIC MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 40: GLOBAL AMBULATORY SURGICAL CENTER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL AMBULATORY SURGICAL CENTER MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 42: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 44: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 46: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 47: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 48: NORTH AMERICA ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK

TABLE 49: KEY PLAYERS OPERATING IN NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET

TABLE 50: EUROPE ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 51: EUROPE ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 52: EUROPE ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK

TABLE 53: KEY PLAYERS OPERATING IN EUROPE ARTIFICIAL BLOOD VESSELS MARKET

TABLE 54: ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 55: ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 56: ASIA-PACIFIC ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK

TABLE 57: KEY PLAYERS OPERATING IN ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET

TABLE 58: REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 59: REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 60: REST OF WORLD ARTIFICIAL VESSELS MARKET REGULATORY FRAMEWORK

TABLE 61: KEY PLAYERS OPERATING IN REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET

TABLE 62: LIST OF MERGERS & ACQUISITIONS

TABLE 63: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 64: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 65: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA

FIGURE 4: GROWTH PROSPECT MAPPING FOR EUROPE

FIGURE 5: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC

FIGURE 6: GROWTH PROSPECT MAPPING FOR REST OF WORLD

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: VALUE CHAIN ANALYSIS

FIGURE 10: KEY BUYING CRITERIA

FIGURE 11: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023

FIGURE 12: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)

FIGURE 13: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)

FIGURE 14: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY POLYURETHANE, 2024-2032 (IN $ MILLION)

FIGURE 15: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)

FIGURE 16: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY BLOOD VESSEL DIAMETER, IN 2023

FIGURE 17: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY LARGE, 2024-2032 (IN $ MILLION)

FIGURE 18: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY MEDIUM, 2024-2032 (IN $ MILLION)

FIGURE 19: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY SMALL, 2024-2032 (IN $ MILLION)

FIGURE 20: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY PATIENT DEMOGRAPHICS, IN 2023

FIGURE 21: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY PEDIATRIC, 2024-2032 (IN $ MILLION)

FIGURE 22: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY ADULT, 2024-2032 (IN $ MILLION)

FIGURE 23: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 24: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY PERIPHERAL ARTERY, 2024-2032 (IN $ MILLION)

FIGURE 25: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY HEMODIALYSIS, 2024-2032 (IN $ MILLION)

FIGURE 26: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY AORTIC DISEASE, 2024-2032 (IN $ MILLION)

FIGURE 27: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023

FIGURE 28: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY HOSPITAL, 2024-2032 (IN $ MILLION)

FIGURE 29: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY SPECIALTY CLINIC, 2024-2032 (IN $ MILLION)

FIGURE 30: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY AMBULATORY SURGICAL CENTER, 2024-2032 (IN $ MILLION)

FIGURE 31: GLOBAL ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)

FIGURE 32: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 33: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 34: CANADA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 35: EUROPE ARTIFICIAL BLOOD VESSELS MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 36: UNITED KINGDOM ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 37: GERMANY ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 38: FRANCE ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 39: ITALY ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 40: SPAIN ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 41: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 42: POLAND ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 43: REST OF EUROPE ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 44: ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN%)

FIGURE 45: CHINA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 46: JAPAN ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 47: INDIA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 48: SOUTH KOREA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 49: INDONESIA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 50: THAILAND ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 51: VIETNAM ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 52: AUSTRALIA & NEW ZEALAND ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 53: REST OF ASIA-PACIFIC ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 54: REST OF WORLD ARTIFICIAL BLOOD VESSELS MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 55: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FIGURE 56: MIDDLE EAST & AFRICA ARTIFICIAL BLOOD VESSELS MARKET, 2024-2032 (IN $ MILLION)

FAQ’s

FAQs

Yes, artificial blood vessels are engineered to be biocompatible, ensuring they are compatible with the human body and do not cause adverse reactions or immune responses.

Yes, technological advancements enable the customization of artificial blood vessels to meet the specific size and shape requirements of individual patients.

Artificial blood vessels undergo stringent sterilization processes to ensure they are free from contaminants and pathogens, commonly using methods such as gamma irradiation or ethylene oxide sterilization.

Request Customization
Request Customization
Request free sample